The bisphosphonate acute phase response: rapid and copious production of proinflammatory cytokines by peripheral blood gd T cells in response to aminobisphosphonates is inhibited by statins
about
Bisphosphonates: mechanism of action and role in clinical practiceThe promise of γδ T cells and the γδ T cell receptor for cancer immunotherapyDiscovery of Novel Allosteric Non-Bisphosphonate Inhibitors of Farnesyl Pyrophosphate Synthase by Integrated Lead FindingAcute bilateral uveitis and right macular edema induced by a single infusion of zoledronic acid for the treatment of postmenopausal osteoporosis as a substitution for oral alendronate: a case reportOsteoporosis piece of multi-morbidity puzzle in geriatric care.Bisphosphonates and atrial fibrillation: Bayesian meta-analyses of randomized controlled trials and observational studies.Bisphosphonates and osteonecrosis of the jaw: moving from the bedside to the bench.Efficacy and safety of zoledronic acid in the treatment of glucocorticoid-induced osteoporosis.Intravenous zoledronic acid for the treatment of osteoporosis: The evidence of its therapeutic effect.Long-term treatment with bisphosphonates and their safety in postmenopausal osteoporosis.Acute effects of intravenous administration of pamidronate in patients with osteoporosis.A Novel Prothrombotic Pathway in Systemic Sclerosis Patients: Possible Role of Bisphosphonate-Activated γδ T Cells.Potential pathophysiological mechanisms in osteonecrosis of the jaw.In vivo effects of zoledronic acid on oral mucosal epithelial cellsIntravenous bisphosphonates for postmenopausal osteoporosis: safety profiles of zoledronic acid and ibandronate in clinical practice.Atrial fibrillation and the use of oral bisphosphonates.Safety and tolerability of zoledronic acid and other bisphosphonates in osteoporosis management.Fluorescent risedronate analogues reveal bisphosphonate uptake by bone marrow monocytes and localization around osteocytes in vivoExtraskeletal benefits and risks of calcium, vitamin D and anti-osteoporosis medicationsSevere polyarthritis secondary to zolendronic acid: a case report and literature reviewInflammatory ocular adverse events with the use of oral bisphosphonates: a retrospective cohort studyBisphosphonates for the treatment of osteoporosis: insights for clinicians.Suppression of CYP2B induction by alendronate-mediated farnesyl diphosphate synthase inhibition in primary cultured rat hepatocytes.Zoledronic acid for treatment of Paget's disease of bone.Significance and impact of bisphosphonate-induced acute phase responses.Relationship of Bisphosphonate Therapy and Atrial Fibrillation/Flutter: Outcomes of Sleep Disorders in Older Men (MrOS Sleep) Study.Bone vascularization in normal and disease conditions.Bisphosphonate use is associated with reduced risk of myocardial infarction in patients with rheumatoid arthritis.Activated γδ T cells inhibit osteoclast differentiation and resorptive activity in vitro.Profound muscle weakness and pain after one dose of actonel.Effects of RANKL-Targeted Therapy in Immunity and Cancer.Pro-inflammatory and anti-angiogenic effects of bisphosphonates on human cultured retinal pigment epithelial cells.Atrial fibrillation and bisphosphonate therapy.Bisphosphonates in the treatment of metabolic bone diseases.Managing bone health with zoledronic acid: a review of randomized clinical study results.Use of bisphosphonate and risk of atrial fibrillation in older women with osteoporosis.Safety of long-term bisphosphonate therapy for the management of osteoporosis.Fracture mortality: associations with epidemiology and osteoporosis treatment.Prevention of Vγ9Vδ2 T Cell Activation by a Vγ9Vδ2 TCR Nanobody.Vitamin D reduces musculoskeletal pain after infusion of zoledronic acid for postmenopausal osteoporosis.
P2860
Q24644708-AEB8BCC5-A81E-4BB0-9494-E5B7CEF86B5BQ26859775-F4833268-5E7B-47A4-B69A-ADD048F9D568Q27702178-968A71BC-8642-4E34-A684-CAF08F238CF9Q28079912-D9794B00-A299-4CDB-8FA5-187C66141C49Q33351754-DF46B26D-9834-45C5-9EA9-BECB8284C72CQ33505798-2CA774BE-7ED2-41D0-BF87-89E0F06ADC68Q33666457-52DBA3B9-4C66-4AAB-B8B7-86625D98DE13Q33886852-F0299C0B-642F-44B9-ACC6-C220A4A2DB3FQ33973902-A14CE933-3416-4D0B-9A11-F26E5723969CQ34018048-695AA1AD-AFB4-47F3-BD11-FC2C6C95258BQ34073677-CE3C8C79-2ACE-4DFE-BD0A-CF34205EFC25Q34148693-8CF206E9-4666-409A-90FE-E0B215380D1AQ34162359-3974F3BA-7943-450A-9257-C9D56BB644DEQ34441640-9F16AFA6-5B63-45CD-9CD1-179B48AA534DQ34645740-1C526A37-CE88-4A16-9276-926A80689172Q34764869-646D2CB0-0ADF-4726-A472-0CFB9AE863D0Q35026446-4967AB7A-D85C-4CF6-8FE1-86E193E5BCE3Q35156294-BDC61532-BA5A-4F1F-93E8-89386FB7D5DFQ35740351-7F6CC374-DC60-4B75-9EEF-39F948E03B7AQ35747575-5F30C6D8-82B9-4CBA-B78D-3CA50EA83E13Q35946372-98CBF4B6-66F7-4E27-94F7-BF250E47E4A5Q36443681-6780F49E-ABC8-476D-AD80-8C08F3DD9966Q36920135-657A487C-80E8-43F1-8D12-79868CBC17BBQ36979355-0E866DB8-F8D4-4E35-A4CD-429A6C487A77Q37018333-CBA8DB49-CED2-4509-A1B9-75434C017458Q37094648-A9DBCA4B-3A68-4F62-9D41-DD886DF2C6F3Q37119026-F56ED8DB-100E-45AD-9D43-2EC9CAC8060BQ37307297-7C4885CB-B166-468E-8D9E-3003CF999C76Q37310557-12432232-83DC-42E1-B857-73EAC362FC06Q37383277-017686BF-53DF-4804-89A9-9BF098B6939EQ37441693-6C27B3E1-F318-40E2-BC4C-D8301B91C913Q37626356-1869D093-F0CD-454D-9EF3-BACC436ED3DAQ37679127-DFC210BB-9DDD-41F0-899E-BA737F793BD5Q37756594-42B8C6F0-B39F-4921-A14D-4C0FE89E6DA7Q37823605-00345CF1-A877-463A-B9AC-9339A514580CQ37856911-AFD07F4D-9FAB-4A73-9237-B43913C2A1AFQ37866764-99BA979B-0CA1-4917-B18F-DFBE4C28FCDFQ38236887-7895EDDB-54EC-413C-8BCE-480ED24BA94CQ38728528-5654B45C-DADE-4474-9536-1336C997ECE8Q40295687-0BCE378E-3101-445D-B375-1D90FC15BC03
P2860
The bisphosphonate acute phase response: rapid and copious production of proinflammatory cytokines by peripheral blood gd T cells in response to aminobisphosphonates is inhibited by statins
description
2005 nî lūn-bûn
@nan
2005 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
The bisphosphonate acute phase ...... onates is inhibited by statins
@ast
The bisphosphonate acute phase ...... onates is inhibited by statins
@en
The bisphosphonate acute phase ...... onates is inhibited by statins
@nl
type
label
The bisphosphonate acute phase ...... onates is inhibited by statins
@ast
The bisphosphonate acute phase ...... onates is inhibited by statins
@en
The bisphosphonate acute phase ...... onates is inhibited by statins
@nl
prefLabel
The bisphosphonate acute phase ...... onates is inhibited by statins
@ast
The bisphosphonate acute phase ...... onates is inhibited by statins
@en
The bisphosphonate acute phase ...... onates is inhibited by statins
@nl
P2093
P2860
P1476
The bisphosphonate acute phase ...... onates is inhibited by statins
@en
P2093
P2860
P304
P356
10.1111/J.1365-2249.2005.02665.X
P407
P577
2005-01-01T00:00:00Z